Pathophysiology of glaucoma and continuous measurements of intraocular pressure

Arthur J Sit, John H K Liu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Glaucoma is a leading cause of visual impairment and blindness worldwide. The main risk factor for glaucoma is an elevated intraocular pressure (IOP), which is also the only currently treatable risk factor. Despite its importance, our understanding of IOP is incomplete and our ability to measure IOP is limited. IOP is known to undergo both random fluctuations as well as variations following a circadian pattern. In humans, IOP is highest at night and lower during the daytime, largely due to changes in body position, although other factors appear to contribute. In rabbits, IOP is also highest at night and lower during the day, likely due to circadian variations in sympathetic nervous system activity. Random and circadian IOP variations may be important to glaucoma pathogenesis, independent of the diurnal IOP level. However, due to limitations with current IOP measurement technology, clinical practice typically involves only a few IOP measurements per year. As well, current technology does not allow 24-hour monitoring of pressure without the use of sleep laboratories or hospital admission. Two strategies for automating IOP measurement are temporary (non-invasive) monitoring and permanent (implantable) monitoring. Efforts at developing devices to allow continuous IOP monitoring have occurred for over 40 years without producing a clinical device. Current technological progress would seem to suggest that such devices are possible at this time, and a review of previous attempts provides guidelines for their development.

Original languageEnglish (US)
Pages (from-to)57-69
Number of pages13
JournalMCB Molecular and Cellular Biomechanics
Volume6
Issue number1
StatePublished - 2009

Fingerprint

Intraocular Pressure
Glaucoma
Equipment and Supplies
Technology
Hospital Laboratories
Aptitude
Vision Disorders
Sympathetic Nervous System
Blindness
Sleep
Guidelines
Rabbits
Pressure

ASJC Scopus subject areas

  • Cell Biology
  • Biophysics
  • Molecular Biology
  • Molecular Medicine

Cite this

Pathophysiology of glaucoma and continuous measurements of intraocular pressure. / Sit, Arthur J; Liu, John H K.

In: MCB Molecular and Cellular Biomechanics, Vol. 6, No. 1, 2009, p. 57-69.

Research output: Contribution to journalArticle

@article{5ff8b494fce748c0a92e3d38641b1248,
title = "Pathophysiology of glaucoma and continuous measurements of intraocular pressure",
abstract = "Glaucoma is a leading cause of visual impairment and blindness worldwide. The main risk factor for glaucoma is an elevated intraocular pressure (IOP), which is also the only currently treatable risk factor. Despite its importance, our understanding of IOP is incomplete and our ability to measure IOP is limited. IOP is known to undergo both random fluctuations as well as variations following a circadian pattern. In humans, IOP is highest at night and lower during the daytime, largely due to changes in body position, although other factors appear to contribute. In rabbits, IOP is also highest at night and lower during the day, likely due to circadian variations in sympathetic nervous system activity. Random and circadian IOP variations may be important to glaucoma pathogenesis, independent of the diurnal IOP level. However, due to limitations with current IOP measurement technology, clinical practice typically involves only a few IOP measurements per year. As well, current technology does not allow 24-hour monitoring of pressure without the use of sleep laboratories or hospital admission. Two strategies for automating IOP measurement are temporary (non-invasive) monitoring and permanent (implantable) monitoring. Efforts at developing devices to allow continuous IOP monitoring have occurred for over 40 years without producing a clinical device. Current technological progress would seem to suggest that such devices are possible at this time, and a review of previous attempts provides guidelines for their development.",
author = "Sit, {Arthur J} and Liu, {John H K}",
year = "2009",
language = "English (US)",
volume = "6",
pages = "57--69",
journal = "MCB Molecular and Cellular Biomechanics",
issn = "1556-5297",
publisher = "Tech Science Press",
number = "1",

}

TY - JOUR

T1 - Pathophysiology of glaucoma and continuous measurements of intraocular pressure

AU - Sit, Arthur J

AU - Liu, John H K

PY - 2009

Y1 - 2009

N2 - Glaucoma is a leading cause of visual impairment and blindness worldwide. The main risk factor for glaucoma is an elevated intraocular pressure (IOP), which is also the only currently treatable risk factor. Despite its importance, our understanding of IOP is incomplete and our ability to measure IOP is limited. IOP is known to undergo both random fluctuations as well as variations following a circadian pattern. In humans, IOP is highest at night and lower during the daytime, largely due to changes in body position, although other factors appear to contribute. In rabbits, IOP is also highest at night and lower during the day, likely due to circadian variations in sympathetic nervous system activity. Random and circadian IOP variations may be important to glaucoma pathogenesis, independent of the diurnal IOP level. However, due to limitations with current IOP measurement technology, clinical practice typically involves only a few IOP measurements per year. As well, current technology does not allow 24-hour monitoring of pressure without the use of sleep laboratories or hospital admission. Two strategies for automating IOP measurement are temporary (non-invasive) monitoring and permanent (implantable) monitoring. Efforts at developing devices to allow continuous IOP monitoring have occurred for over 40 years without producing a clinical device. Current technological progress would seem to suggest that such devices are possible at this time, and a review of previous attempts provides guidelines for their development.

AB - Glaucoma is a leading cause of visual impairment and blindness worldwide. The main risk factor for glaucoma is an elevated intraocular pressure (IOP), which is also the only currently treatable risk factor. Despite its importance, our understanding of IOP is incomplete and our ability to measure IOP is limited. IOP is known to undergo both random fluctuations as well as variations following a circadian pattern. In humans, IOP is highest at night and lower during the daytime, largely due to changes in body position, although other factors appear to contribute. In rabbits, IOP is also highest at night and lower during the day, likely due to circadian variations in sympathetic nervous system activity. Random and circadian IOP variations may be important to glaucoma pathogenesis, independent of the diurnal IOP level. However, due to limitations with current IOP measurement technology, clinical practice typically involves only a few IOP measurements per year. As well, current technology does not allow 24-hour monitoring of pressure without the use of sleep laboratories or hospital admission. Two strategies for automating IOP measurement are temporary (non-invasive) monitoring and permanent (implantable) monitoring. Efforts at developing devices to allow continuous IOP monitoring have occurred for over 40 years without producing a clinical device. Current technological progress would seem to suggest that such devices are possible at this time, and a review of previous attempts provides guidelines for their development.

UR - http://www.scopus.com/inward/record.url?scp=65549125959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549125959&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 57

EP - 69

JO - MCB Molecular and Cellular Biomechanics

JF - MCB Molecular and Cellular Biomechanics

SN - 1556-5297

IS - 1

ER -